Current Build

4.4.1.348 Value Set http://hl7.org/fhir/ValueSet/condition-stage

Patient Care Work Group Maturity Level: 1Draft Use Context: Not Intended for Production use

This is a value set defined at http://www.hl7.org/Special/committees/patientcare/ .

Summary

Defining URL:http://hl7.org/fhir/ValueSet/condition-stage
Version:3.6.0
Name:ConditionStage
Title:Condition Stage
Definition:

Example value set for stages of cancer and other conditions

Committee:Patient Care Work Group
OID:2.16.840.1.113883.4.642.3.170 (for OID based terminology systems)
Copyright:This resource includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org
Source ResourceXML / JSON

This value set is used in the following places:


This value set includes codes from the following code systems:

 

This expansion generated 21 Nov 2018


This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

All codes from system http://snomed.info/sct

CodeDisplayDefinition
786005 Clinical stage I B
1523005 Clinical stage IV B
2640006 Clinical stage 4
2786004 Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage III
5701003 Lymphoma stage IIe
5856006 N3 stage
6123003 pT4 stage
6534007 Epithelial ovarian tumor, FIGO stage IIA
13104003 Clinical stage I
14410001 Tumor stage T3
14926007 pM1: Distant metastasis
14927003 FIGO VC stage II
15076001 pN2 category
15540006 International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage I
15542003 Clinical stage I C
17076002 pMX: Distant metastasis cannot be assessed
17691001 Clinical stage I S
17816005 Clinical stage II B
19408000 pM0: No distant metastasis
21917009 pN0 category
22079002 N4 category
22364004 International Federation of Gynecology and Obstetrics vulvar carcinoma (FIGO VC) stage III
23351008 Tumor stage T1
25654007 International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage Ib
27167007 Metastasis stage MX
30382004 International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage II
30440004 Lymphoma stage I
30893008 Metastasis stage M0
31747005 Modified Dukes stage B1
33177002 Clinical stage IV C
33907000 Clinical stage III E
34537009 International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IV
35440002 Clinical stage I D
36018006 Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IA
37415008 Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IC
39617003 Clinical stage II C
39880006 pT0 category
43189003 pTX category
44255004 Lymphoma stage IIIe
44401000 Tumor stage Tis
45552005 pN1 category
46059003 Node stage N2
46333007 Clinical stage 1 A
46756001 International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage I A
48105005 Clinical stage 3 C
49182004 pN3 category
49219005 International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage Ia
50237009 International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage I
50283003 Clinical stage III
52708004 International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage III
52774001 Clinical stage 2 A
52865009 Clinical stage IV D
53173007 Modified Dukes stage B2
53623008 Node stage N1
53786006 pT1 category
54452005 pNX category
54498006 Modified Dukes stage C1
55336000 Clinical stage III D
55440008 Metastasis stage M1
56380009 Clinical stage I E
56587006 International Federation of Gynecology and Obstetrics vulvar carcinoma (FIGO VC) stage I
56769006 Modified Dukes stage A
56944001 Lymphoma stage III
57306005 Modified Dukes stage C2
57605004 Modified Dukes stage D
58790005 Tumor stage T0
60275007 FIGO EC stage I B
60333009 Clinical stage II
62455006 N0 stage
64062008 Clinical stage III B
64202001 Clinical stage IV E
64574000 Epithelial ovarian tumor, FIGO stage IIB
64737002 Epithelial ovarian tumor, FIGO stage IB
64877001 Clinical stage III S
65235001 Epithelial ovarian tumor, FIGO stage I
65306007 FIGO VM stage II
65536004 FIGO VM stage III
65565005 T4 stage
66445009 Lymphoma stage IV
67101007 TX stage
67673008 T2 stage
68240008 FIGO CC stage II
69605008 Clinical stage II E
70046009 FIGO VM stage I
70664003 Clinical stage IV S
71725004 Clinical stage IV A
72780008 FIGO VC stage IV
73055006 FIGO VM stage V
73082003 Clinical stage III A
73511008 Epithelial ovarian tumor, FIGO stage IV
74053007 Lymphoma stage IIIs
75339006 Lymphoma stage III 2
76422004 Lymphoma stage II
78199001 Epithelial ovarian tumor, FIGO stage IIC
78607009 Epithelial ovarian tumor, FIGO stage II
79420006 Node stage NX
80588003 FIGO VM stage IV
80663004 pN4 stage
80898003 pT2 stage
80975007 FIGO EC stage III
81822003 FIGO CC stage IV
84633001 Lymphoma stage IIIse
84921008 pTis stage
87977001 International Federation of Gynecology and Obstetrics cervical cancer stage Ib occ
89487002 Lymphoma stage Ie
90321006 Clinical stage II S
90402004 pT3 stage
112240001 Clinical stage II D
112241002 Lymphoma stage III 1
258297005 Metastasis stage M2
258298000 Metastasis stage M3
258299008 Metastasis stage M4
261646003 Tumor stage T1a
261647007 Tumor stage T1a1
261648002 Tumor stage T1a2
261649005 Tumor stage T1b
261650005 Tumor stage T1c
261651009 Tumor stage T2a
261652002 Tumor stage T2b
261653007 Tumor stage T2c
261654001 Tumor stage T3a
261655000 Tumor stage T3b
261656004 Tumor stage T3bi
261657008 Tumor stage T3bii
261658003 Tumor stage T3c
261659006 Tumor stage T4a
261660001 Tumor stage T4b
261661002 Tumor stage T4c
261662009 Tumor stage T4d
261927002 Metastasis stage M1a
261928007 Metastasis stage M1b
261929004 Metastasis stage M1c
261967001 Node stage N2a
261968006 Node stage N2b
261969003 Node stage N2c
277672002 Node stage N1a
277674001 Node stage N1b
277744001 Metastasis stage pM1
277772008 Node stage N1bi
277776006 Node stage N1bii
277777002 Node stage N1biii
277778007 Node stage N1biv
313108002 Tumor stage T1mic
313110000 Tumor stage T1b1
313111001 Tumor stage T1b2
313145008 Tumor stage Tis pu
313146009 Tumor stage Tis pd
369793000 Tis (--): Carcinoma in situ (endometrium / uterine cervix)
369794006 T1 (I): Cervical carcinoma confined to uterus
369795007 T1a (IA): Invasive carcinoma of uterine cervix diagnosed by microscopy only
369796008 T1a1 (IA1): Tumor of uterine cervix with stromal invasion < 3.0 mm in depth and horizontal spread < 7.0 mm
369797004 T1a2 (IA2): Tumor of uterine cervix with stromal invasion > 3.0 mm but < 5.0 mm in depth and horizontal spread < 7.0 mm
369798009 T1b (IB): Tumor of uterine cervix with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2
369799001 T1b1 (IB1): Tumor of uterine cervix, clinically visible lesion < 4.0 mm in greatest dimension
369800002 T1b2 (IB2): Tumor of uterine cervix, clinically visible lesion > 4.0 mm in greatest dimension
369801003 T2 (II): Tumor of uterine cervix invades beyond the uterus but not to pelvic wall or to lower third of vagina
369802005 T2a (IIA): Tumor of uterine cervix, T2 without parametrial invasion
369803000 T2b (IIB): Tumor of uterine cervix, T2 with parametrial invasion
369804006 T3 (III): Tumor of uterine cervix extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or nonfunctioning kidney
369805007 T3a (IIIA): Tumor of uterine cervix involves lower third of vagina, but not pelvic wall
369806008 T4 (IVA): Tumor of uterine cervix/vagina invades mucosa of bladder or rectum and/or extends beyond true pelvis
369807004 T1 (I): Endometrial tumor confined to corpus uteri
369808009 T1a (IA): Tumor limited to endometrium
369809001 T1b (IB): Endometrial tumor invades up to or less than one half of the endometrium
369810006 T1c (IC): Endometrial tumor invades to more than one half of the endometrium
369811005 T2 (II): Endometrial tumor invades cervix, but does not extend beyond uterus
369812003 T2a (IIA): Endometrial tumor with endocervical glandular involvement
369813008 T2b (IIB): Endometrial tumor with cervical stromal invasion
369814002 T3 (III): Endometrial tumor with local and/or regional spread as specified in T3a, b, N1 and FIGO IIIA, B, and C below or adnexa (direct extension or metastasis) and/or cancer cells in ascites or peritoneal washings
369815001 T3b (IIIB): Endometrial tumor with vaginal involvement (direct extension or metastasis)
369816000 T4 (IVA): Endometrial tumor invades bladder mucosa and/or bowel mucosa
369817009 T1 (I): Tumor confined to vagina
369818004 T2 (II): Vaginal tumor invades paravaginal tissues but not to pelvic wall
369819007 T3 (III): Vaginal tumor extends to pelvic wall
369820001 T1 (I): Tumor limited to fallopian tube(s)
369821002 T1a (IA): Tumor limited to one fallopian tube without penetrating the serosal surface, no ascites
369822009 T1b (IB): Tumor limited to both tubes without penetrating the serosal surface: no ascites
369823004 T1c (IC): Tumor limited to one or both tube(s) with extension into or through the tubal serosa; or with malignant cells in ascites or peritoneal washings: FALLOPIAN TUBE: Salpingectomy
369824005 T2 (II): Fallopian tube tumor involves one or both tube(s) with pelvic extension
369825006 T2a (IIA): Fallopian tube tumor with extension and/or metastasis to the uterus and/or ovaries
369826007 T2b (IIB): Fallopian tube/ovarian tumor with extension to other pelvic structures
369827003 T2c (IIC): Fallopian tube/ovarian tumor with pelvic extension (T2a or b) with malignant cells in ascites or peritoneal washings
369828008 T3 and/or N1 (III): Fallopian tube tumor involves one or both tube(s) with peritoneal implants outside the pelvis and/or regional lymph node metastasis
369829000 T3a (IIIA): Fallopian tube/ovarian tumor with microscopic peritoneal metastasis beyond pelvis
369830005 T3b (IIIB): Fallopian tube/ovarian tumor with macroscopic peritoneal metastasis beyond pelvis < 2 cm in greatest dimension
369831009 T3c (IIIC): Fallopian tube/ovarian tumor with peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis
369832002 T1: Clinically inapparent prostate tumor not palpable or visible by imaging
369833007 T1a: Prostate tumor incidental histologic finding in 5% or less of tissue resected
369834001 T1b: Prostate tumor incidental histologic finding in > 5% of tissue resected
369835000 T1c: Tumor identified by needle biopsy because of elevated prostate specific antigen: PROSTATE: Biopsy/transurethral resection: PROSTATE: Resection
369836004 T2a: Prostate tumor involves one lobe
369837008 T3: Prostate tumor extends through the prostatic capsule
369838003 T3a: Prostate tumor with extracapsular extension (unilateral or bilateral)
369839006 T3b: Prostate tumor invades the seminal vesicle(s)
369840008 T2: Aerodigestive tract tumor causing bone erosion or destruction, except for the posterior antral wall, including extension into hard palate and/or middle nasal meatus
369841007 T1: Aerodigestive tract tumor < 2 cm in greatest dimension
369842000 T1: Aerodigestive tract tumor confined to ethmoid with or without bone erosion
369843005 T1: Aerodigestive tract tumor confined to nasopharynx
369844004 T1: Tumor limited to one subsite of hypo-pharynx and < 2 cm in greatest dimension
369845003 T1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility
369846002 T1: Tumor limited to subglottis
369847006 T1: Tumor limited to the antral mucosa with no erosion or destruction of bone
369848001 T1: Tumor limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility
369849009 T1a: Tumor limited to one vocal cord
369850009 T1b: Tumor involves both vocal cords
369851008 T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension
369852001 T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension without extraparenchymal extension
369853006 T2: Aerodigestive tract tumor extends into nasal cavity
369854000 T2: Aerodigestive tract tumor extends to soft tissue of oropharynx and/or nasal fossa
369855004 T2: Aerodigestive tract tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility
369856003 T2: Aerodigestive tract tumor extends to vocal cord(s) with normal or impaired mobility
369857007 T2: Aerodigestive tract tumor invades more than one subsite of hypopharynx or an adjacent site, or measures > 2 cm but < 4 cm in greatest dimension, without fixation of hemilarynx
369858002 T2: Aerodigestive tract tumor invades mucosa of >1 adjacent subsite of supraglottis/glottis/region outside supraglottis, (mucosa of base of tongue/vallecula/medial wall of piriform sinus) without fixation of larynx
369859005 T2a: Aerodigestive tract tumor without parapharyngeal extension
369860000 T2b: Aerodigestive tract tumor with parapharyngeal extension
369861001 T3: Aerodigestive tract tumor > 4 cm in greatest dimension
369862008 T3: Aerodigestive tract tumor extends to anterior orbit and/or maxillary sinus
369863003 T3: Aerodigestive tract tumor having extraparenchymal extension without seventh nerve involvement, and/or > 4 cm but < 6 cm in greatest dimension
369864009 T3: Aerodigestive tract tumor invades any of the following: bone of posterior wall of maxillary sinus, subcutaneous tissues, skin of cheek, floor or medial wall of orbit, infratemporal fossa, pterygoid plates, ethmoid sinuses
369865005 T3: Aerodigestive tumor invades bony structures and/or paranasal sinuses
369866006 T3: Aerodigestive tract tumor limited to larynx with vocal cord fixation
369867002 T3: Aerodigestive tract tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic tissues, deep base of tongue
369868007 T3: Aerodigestive tract tumor measures > 4 cm in greatest dimension, or with fixation of hemilarynx
369869004 T4: Lip: Tumor invades adjacent structures (cortical bone, inferior alveolar nerve, floor of mouth, skin of face)
369870003 T4: Oral Cavity: Tumor invades adjacent structures (cortical bone, deep (extrinsic) muscle of tongue, maxillary sinus, skin)
369871004 T4: Aerodigestive tract tumor invades adjacent structures (pterygoid muscles, mandible, hard palate, deep muscle of tongue, larynx)
369872006 T4: Aerodigestive tract tumor invades adjacent structures (thyroid/cricoid cartilage, carotid artery, soft tissues of neck, prevertebral fascia/muscles, thyroid and/or esophagus)
369873001 T4: Aerodigestive tumor invades base of skull, seventh nerve, and/or exceeds 6 cm in greatest dimension
369874007 T4: Aerodigestive tract tumor invades orbital contents beyond the floor or medial wall including apex and/or any of the following: cribriform plate, base of skull, nasopharynx, sphenoid sinus, frontal sinus
369875008 T4: Tumor invades through cricoid or thyroid cartilage and/or extends into other tissues beyond the larynx (trachea, soft tissues of neck, thyroid, esophagus)
369876009 T4: Tumor invades through thyroid cartilage and/or extends to other tissues beyond the larynx (trachea, soft tissues of neck, pharynx)
369877000 T4: Tumor invades through thyroid cartilage, and/or extends into soft tissues of the neck, thyroid, and/or esophagus
369878005 T4: Aerodigestive tract tumor with intracranial extension and/or involvement of cranial nerves, infratemporal fossa, hypopharynx or orbit
369879002 T4: Aerodigestive tract tumor with intracranial extension, orbital extension including apex, involving sphenoid and/or frontal sinus and/or skin of nose
369880004 T1: Lung tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus
369881000 T2:Lung tumor with any of these features:>3cm in greatest dimension, involves main bronchus >2cm distal to carina; invades visceral pleura; assoc with atelectasis/obstructive pneumonitis extends to hilar region, does not involve entire lung
369882007 T3: Lung tumor of any size associated atelectasis or obstructive pneumonitis of the entire lung
369883002 T3: Lung tumor of any size in the main bronchus < 2 cm distal to the carina but without involvement of the carina
369884008 T3: Lung tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors); diaphragm; mediastinal pleura; parietal pericardium
369885009 T4: Lung tumor of any size that invades any of the following: mediastinum; heart; great vessels; trachea; esophagus; vertebral body; carina
369886005 T4: Lung tumor of any size with a malignant pleural effusion
369887001 T4: Lung tumor of any size with separate tumor nodule(s) in same lobe
369888006 T1: Kidney tumor < 7.0 cm in greatest dimension limited to the kidney
369889003 T2: Renal tumor > 7.0 cm in greatest dimension limited to the kidney
369890007 T3: Renal tumor extends into major veins or invades the adrenal gland or perinephric tissues but not beyond Gerota fascia
369891006 T3a: Renal tumor invades the adrenal gland or perinephric tissues but not beyond Gerota fascia
369892004 T3b: Renal tumor grossly extends into the renal vein(s) or vena cava below the diaphragm
369893009 T3c: Renal tumor grossly extends into the vena cava above the diaphragm
369894003 T4: Renal tumor invades beyond Gerota fascia
369895002 T1: Breast tumor <= 2 cm in greatest dimension
369896001 T1mic: Microinvasion <= 0.1 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy
369897005 T1a: Breast tumor >0.1 cm but <= 0.5 cm in greatest dimension
369898000 T1b: Breast tumor >0.5 cm but <= 1 cm in greatest dimension
369899008 T1c: >1 cm but <= 2 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy
369900003 T2: Breast tumor > 2 cm but <= 5 cm in greatest dimension
369901004 T3: Breast tumor >5 cm in greatest dimension
369902006 T4: Breast tumor of any size with direct extension to chest wall or skin
369903001 T4a: Breast tumor with extension to chest wall
369904007 T4b: Edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast
369905008 T4c: Breast tumor, both T4a and T4b
369906009 T4d: Inflammatory carcinoma (breast)
369907000 Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget disease of the nipple with no tumor
369909002 T1: Tumor invades lamina propria or submucosa
369910007 T1a: Esophagus/stomach tumor invades lamina propria
369911006 T1b: Esophagus/stomach tumor invades submucosa
369912004 T2: Tumor invades muscularis propria
369913009 T3: Esophageal tumor invades adventitia
369914003 T4: Tumor directly invades adjacent structures
369915002 T2: Stomach tumor invades muscularis propria or subserosa
369916001 T2a: Stomach tumor invades muscularis propria
369917005 T2b: Stomach tumor invades subserosa
369918000 T3: Stomach tumor penetrates serosa without invasion of adjacent structures
369919008 T4a: Colon/rectum tumor directly invades other organs or structures
369920002 T1: Tumor invades submucosa (colon/rectum)
369921003 T3: Colon/rectum tumor invades through the muscularis propria into the subserosa or the nonperitonealized pericolic or perirectal soft tissues
369922005 T4b: Colon/rectum tumor penetrates the visceral peritoneum
369923000 Tis (0): Carcinoma in situ (vagina)
369924006 Tis (0): Carcinoma in situ (limited to fallopian tube mucosa)
369925007 Tis: Epithelium only (carcinoma in situ, no invasion)
369926008 T1: Tumor limited to ampulla of Vater or sphincter of Oddi
369927004 T2: Ampulla tumor invades duodenal wall
369928009 T3: Ampulla tumor invades 2 cm or less into pancreas
369929001 T4: Ampulla tumor invades >2 cm into pancreas and/or into other adjacent organs
369930006 T1: Tumor limited to pancreas and < 2 cm in greatest dimension
369931005 T2: Tumor limited to pancreas and > 2 cm in greatest dimension
369932003 T3: Pancreatic tumor extends directly to any of the following: duodenum; bile duct; peripancreatic tissues
369933008 T4: Pancreas tumor extends directly to any of the following: stomach; spleen; colon; adjacent large vessels
369934002 Tis: Carcinoma in situ ("flat tumor" of urinary bladder)
369935001 T1: Urinary tract tumor invades subepithelial connective tissue
369936000 T2: Urinary bladder tumor invades muscle
369937009 T2: Renal pelvis/ureter tumor invades the muscularis
369938004 T2a: Urinary bladder tumor invades superficial muscle (inner half)
369939007 T2b: Urinary bladder tumor invades deep muscle (outer half)
369940009 T3: Ureteral tumor invades beyond muscularis into periureteric fat
369941008 T3: Renal pelvis tumor invades beyond muscularis peripelvic fat or the renal parenchyma
369942001 T3: Urinary bladder tumor invades perivesical tissue
369943006 T3a: Bladder tumor invades perivesical tissue microscopically
369944000 T3b: Bladder tumor invades perivesical tissue macroscopically (extravesicular mass)
369945004 T4: Urinary bladder tumor invades any of the following: prostate, uterus, vagina, pelvic wall abdominal wall
369946003 T4: Renal pelvis/ureter tumor invades adjacent organs, or through the kidney into the perinephric fat
369947007 T4a: Bladder tumor invades prostate or uterus or vagina
369948002 T4b: Bladder tumor invades pelvic wall or abdominal wall
369949005 Ta: Noninvasive papillary carcinoma (urinary tract)
369950005 Tis: Intratubular germ cell neoplasia (carcinoma in situ, testis)
369951009 T1: Testicular tumor limited to the testis and epididymis without vascular/lymphatic invasion (tumor may invade tunica albuginea but not tunica vaginalis)
369952002 T2: Testicular tumor limited to the testis and epididymis with vascular/lymphatic invasion or tumor extending through tunica albuginea with involvement of tunica vaginalis
369953007 T3: Testicular tumor invades spermatic cord with or without vascular/lymphatic invasion
369954001 T4: Testicular tumor invades scrotum with or without vascular/lymphatic invasion
369955000 T1 (I): Trophoblastic disease confined to uterus
369956004 T1 (IA): Trophoblastic disease confined to uterus with no risk factors
369957008 T1 (IB): Trophoblastic disease confined to uterus with one risk factor
369958003 T1 (IC): Trophoblastic disease confined to uterus with two risk factors
369959006 T2 (II): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but is limited to the genital structures (adnexa, vagina, broad ligament)
369960001 T2 (IIA): Trophoblast: GTT involving genital structure without risk factors
369961002 T2 (IIB): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with one risk factor
369962009 T2 (IIC): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with two risk factors
369963004 T1: Tumor limited to ipsilateral parietal and/or visceral pleura
369964005 T2: Pleural tumor invades any of the following: ipsilateral lung, endothoracic fascia, diaphragm, or pericardium
369965006 T3: Pleural tumor invades any of the following: ipsilateral chest wall muscle, ribs, or media-stinal organs or tissues
369966007 T4: Pleural tumor directly extends to any of the following: contralateral pleura, contralateral lung, peritoneum, intra-abdominal organs, cervical tissues
369967003 T1: Tumor size < 1 cm, limited to thyroid
369968008 T2: Tumor > 1 cm but < 4 cm, limited to thyroid
369969000 T3: Thyroid tumor > 4 cm, limited to thyroid
369970004 T4: Thyroid tumor of any size extending beyond the thyroid capsule
369971000 T1a (IA): Tumor limited to one ovary, capsule intact, no tumor on ovarian surface
369972007 T1b (IB): Tumor limited to both ovaries: capsule intact, no tumor on ovarian surface
369973002 T1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings: OVARY: Resection
369974008 T2: Ovarian tumor involves one or both ovaries with pelvic extension
369975009 T2a (IIA): Ovarian tumor with extension and/or implants on uterus and/or tube(s)
369976005 T3 and/or N1 (III): Ovarian tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis
369977001 T3b (IIIB): Tumor of uterine cervix extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney
369978006 T2: Tumor confined within the prostate
369979003 T1: Aerodigestive tract tumor < 2 cm in greatest dimension without extraparenchymal extension
369980000 Tis: Tumor invades lamina propria (gastrointestinal tumor)
369981001 Tis: Tumor invades muscularis mucosae (colon/rectum)
369982008 T1: Solitary liver tumor < 2 cm; no vascular invasion
369983003 N1: Metastasis to movable ipsilateral axillary lymph node(s)
369984009 N1a: Only micrometastasis, none > 0.2 cm in greatest dimension
369985005 N1b: Metastasis to lymph node(s), any > 0.2 cm in greatest dimension
369986006 N1bi: Metastasis in 1 to 3 lymph nodes, any > 0.2 cm and all < 2 cm in greatest dimension
369987002 N1bii: Metastasis in 4 or more lymph nodes, any > 0.2 cm and all < 2 cm in greatest dimension
369988007 N1biii: Extension of tumor beyond the capsule of a lymph node metastasis, < 2 cm in greatest dimension
369989004 N1biv: Metastasis to a lymph node > 2 cm in greatest dimension
369990008 Clinical axillary lymph node metastases - matted
369991007 N3: Metastasis to ipsilateral internal mammary lymph node(s)
369992000 N1: Metastasis in 1-3 lymph nodes
369993005 N2: Metastasis in 4 or more lymph nodes
369994004 N1a: 1-3 nodes involved
369995003 N1b: 4-7 nodes involved
369996002 N1c: >7 nodes involved
369997006 N1: Metastasis in 1-6 perigastric lymph nodes
369998001 N2: Metastasis in 7-15 perigastric lymph nodes
369999009 N3: Metastasis in >15 perigastric lymph nodes
370000006 N1: Metastasis in a single lymph node, < 2 cm in greatest dimension
370001005 N1: Metastasis in a single lymph node, <= 2 cm in greatest dimension
370002003 N2: Metastasis in a single lymph node, > 2 cm but <= 5 cm in greatest dimension, or multiple lymph nodes, none > 5 cm in greatest dimension
370003008 N3: Metastasis in a lymph node > 5 cm in greatest dimension
370004002 N1: Metastasis in a single ipsilateral lymph node, < 3 cm in greatest dimension
370005001 N1: Unilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa
370006000 N2: Metastasis in a single ipsilat lymph node >3cm but <6cm in greatest dimension; or in multiple ipsilat lymph nodes, none >6cm in greatest dimension; or in bilat or contralat lymph nodes, none >6cm in greatest dimension
370007009 N2: Bilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa
370008004 N2a: Metastasis in a single ipsilateral lymph node, > 3 cm but < 6 cm in greatest dimension
370009007 N2b: Metastasis in multiple ipsilateral lymph nodes, none > 6 cm in greatest dimension
370010002 N2c: Metastasis in bilateral or contralateral lymph nodes, none > 6 cm in greatest dimension
370011003 N3: Metastasis in lymph node(s)
370012005 N3a: > 6 cm in dimension
370013000 N3b: extension to supraclavicular fossa
370014006 N3: Metastasis in a lymph node > 6 cm in greatest dimension
370015007 N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor
370016008 N2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)
370017004 N3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph node(s)
370018009 N1: Metastasis in a single lymph node
370019001 N2: Metastasis in more than one regional lymph node
370020007 N1: Metastasis with a lymph node mass less than 2 cm in greatest dimension and 5 or fewer positive nodes, none larger than 2 cm in greatest dimension
370021006 N2: Metastasis with a lymph node mass >2 cm but <= 5 cm in greatest dimension, or more than 5 nodes positive, none > 5 cm; or evidence of extranodal extension of tumor
370022004 N3: Metastasis with a lymph node mass > 5 cm in greatest dimension
370023009 N1: Metastasis in regional lymph node or nodes
370024003 N1: Pelvic or inguinal lymph node metastasis
370025002 N1a: Metastasis in ipsilateral cervical lymph node(s)
370026001 N1b: Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph node(s)
370027005 N1a: Metastasis in single regional lymph node
370028000 N1b: Metastasis in multiple regional lymph nodes
370029008 M1 (IV): Distant metastasis
370030003 M1 (IVB): Distant metastasis
370031004 M1: Distant metastasis [includes metastasis to ipsilateral supraclavicular lymph nodes]
370032006 M1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral)
370033001 M1a: Non-regional lymph node or pulmonary metastasis
370034007 M1a: non-regional lymph node metastasis
370035008 M1a (III): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement
370036009 M1a (IIIA): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement without risk factors
370037000 M1a (IIIB): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with one risk factor
370038005 M1a (IIIC): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with two risk factors
370039002 M1b (IV): All other metastatic sites
370040000 M1b (IVA): All other metastatic sites without risk factors
370041001 M1b (IVB): All other metastatic sites with one risk factor
370042008 M1b (IVC): All other metastatic sites with two risk factors
370043003 M1b: Bone(s)
370044009 M1b: Distant metastasis other than to non-regional lymph nodes and lungs
370045005 M1c: Other site(s)
370046006 T3a,b: Colon/rectum tumor invades <=5 mm beyond the border of the muscularis propria
370047002 T3c,d: Colon/rectum tumor invades >5 mm beyond the border of the muscularis propria
370072002 Direct invasion of adrenal (T3a)
370123006 N1: Regional lymph node metastasis
372436009 N1: Metastasis in perirectal lymph node or nodes
372437000 N2: Metastasis to unilateral internal iliac and/or inguinal lymph node(s)
373150000 pNX: Regional lymph nodes cannot be assessed (e.g., previously removed, or not removed for pathologic study) (breast)
373151001 pN0: No regional lymph node metastasis histologically (i.e., none greater than 0.2 mm), no additional examination for isolated tumor cells (breast)
373156006 pN1: Metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast)
373157002 pN1mi: Micrometastasis (greater than 0.2 mm, none greater than 2.0 mm) (breast)
373158007 pN1mi(i+): Micrometastasis detected only by IHC (breast)
373159004 pN1a: Metastasis in 1 to 3 axillary lymph nodes (breast)
373160009 pN1b: Metastasis in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast)
373161008 pN1c: Metastasis in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast)
373162001 pN2: Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast)
373163006 pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) (breast)
373164000 pN2b: Metastasis in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast)
373165004 pN3a: Metastasis in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm), or metastasis to infraclavicular lymph nodes (breast)
373166003 pN3c: Metastasis in ipsilateral supraclavicular lymph nodes (breast)
373167007 pN3b: Tumor of breast with metastasis as per AJCC 6th Edition definition (breast)
373169005 pM0: No distant metastasis from breast tumor
373170006 pMX: Distant metastasis cannot be assessed (breast)
373171005 pM1: Distant metastasis (breast)
373172003 pT1: Tumor 2 cm or less in greatest dimension (breast)
373173008 pTX: Primary tumor cannot be assessed (breast)
373174002 pT0: No evidence of primary tumor (breast)
373175001 pTis: Carcinoma in situ (breast)
373176000 pTis: Ductal carcinoma in situ (breast)
373177009 pTis: Lobular carcinoma in situ (breast)
373178004 pTis: Paget's disease of the nipple with no tumor
373179007 pT1mic: Microinvasion <= 0.1 cm in greatest dimension (breast)
373180005 pT1a: Tumor >0.1 cm but <= 0.5 cm in greatest dimension (breast)
373182002 pT2: Tumor > 2 cm but <= 5 cm in greatest dimension (breast)
373183007 pT1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension (breast)
373184001 pT3: Tumor >5 cm in greatest dimension (breast)
373185000 pT4: Tumor of any size with direct extension to chest wall or skin (breast)
373186004 pT4a: Tumor of any size with extension to chest wall, not including pectoralis muscle (breast)
373187008 pT4b: Tumor of any size with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast
373189006 pT4c: Tumor of any size with direct extension to chest wall (not including pectoralis muscle) and edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast
373190002 pT4d: Inflammatory carcinoma (breast)
373199001 pTis: Tumor invades muscularis mucosae (colon/rectum)
373200003 pT1: Tumor invades submucosa (colon/rectum)
373201004 pTis: Tumor invades lamina propria (colon/rectum)
373204007 pT1b: Tumor >0.5 cm but <= 1 cm in greatest dimension (breast)
384612007 pT4a: Tumor directly invades other organs or structures (colon/rectum)
384613002 pT4b: Tumor penetrates visceral peritoneum (colon/rectum)
384748000 pM1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral) (lung)
384749008 pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor (lung)
384750008 pN2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes(s) (lung)
384751007 pN3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s) (lung)
384753005 pT1: Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus) (lung)
384754004 pT2: Tumor of lung as per AJCC 6th Edition definition (lung)
384755003 pT3:Tumor directly invades any of following:chest wall,diaphragm,mediastinal pleura,parietal pericardium;or tumor in main bronchus<2 cm distal to carina(not involving it);or assoc atelectasis or obstructive pneumonitis of whole lung
384756002 pT4: Tumor of lung as per AJCC 6th Edition definition (lung)
384757006 pTX: Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy (lung)
384983005 pT2: Organ confined (prostate)
384984004 pT2a: Unilateral, one-half of one lobe or less (prostate)
384985003 pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate)
384986002 pT2c: Bilateral disease (prostate)
384987006 pT3: Extraprostatic extension (prostate)
384988001 pT3a: Extraprostatic extension (prostate)
384989009 pT3b: Seminal vesicle invasion (prostate)
384990000 pT4: Invasion of bladder AND/OR rectum (prostate)
385301007 pT1: Tumor 2 cm or less in greatest dimension (anal canal)
385302000 pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal)
385303005 pT3: Tumor more than 5 cm in greatest dimension (anal canal)
385304004 pT4: Tumor of any size invades adjacent organ(s), e.g., vagina, urethra, bladder (anal canal)
385306002 pN1: Metastasis in perirectal lymph node(s) (anal canal)
385307006 pN2: Metastasis in unilateral internal iliac AND/OR inguinal lymph node(s) (anal canal)
385308001 pN3: Metastasis in perirectal and inguinal lymph nodes AND/OR bilateral internal iliac AND/OR inguinal lymph nodes (anal canal)
385316005 pT1: Tumor invades lamina propria or submucosa (stomach)
385317001 pT1a: Tumor invades lamina propria (stomach)
385318006 pT1b: Tumor invades submucosa (stomach)
385319003 pT2: Tumor invades muscularis propria or subserosa (stomach)
385320009 pT2a: Tumor invades muscularis propria (stomach)
385321008 pT2b: Tumor invades subserosa (stomach)
385322001 pT3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach)
385323006 pT4: Tumor invades adjacent structures (stomach)
385324000 pN1: Metastasis in 1 to 6 regional (perigastric) lymph nodes (stomach)
385325004 pN2: Metastasis in 7 to 15 regional (perigastric) lymph nodes (stomach)
385326003 pN3: Metastasis in more than 15 regional (perigastric) lymph nodes (stomach)
385358008 Dukes stage finding
385360005 Modified Dukes stage finding
385362002 FIGO stage finding for gynecological malignancy
385364001 FIGO ovarian tumor stage finding
385366004 FIGO stage finding for epithelial tumor of ovary
385368003 FIGO stage finding for cervical carcinoma
385370007 FIGO stage finding for vulvar carcinoma
385372004 FIGO stage finding for vulvar melanoma
385374003 FIGO uterine tumor stage finding
385376001 FIGO stage finding for endometrial carcinoma
385378000 pM category finding
385379008 TNM tumor staging finding
385380006 Metastasis stage finding
385381005 pN category finding
385382003 Node stage finding
385385001 pT category finding
385389007 Lymphoma stage finding
385392006 Colon/rectum TNM finding
385415005 Anal canal TNM finding
385416006 Prostate TNM finding
385417002 Breast TNM finding
385418007 Lung TNM finding
394939004 Dukes stage A
394940002 Dukes stage B
394941003 Dukes stage C1
394942005 Dukes stage C2
394943000 Dukes stage D
395705003 pTis: Carcinoma in situ, intraepithelial (colon/rectum)
395706002 pT2: Tumor invades muscularis propria (colon/rectum)
395707006 pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum)
395708001 pT3a,b: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades 5 mm or less beyond the border of the muscularis propria (colon/rectum)
395709009 pT3c,d: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades greater than 5 mm beyond the border of the muscularis propria (colon/rectum)
395710004 pT4: Tumor directly invades other organs or structures and/or perforates visceral peritoneum (colon/rectum)
395711000 pN1: Metastasis in 1 to 3 regional lymph nodes (colon/rectum)
395712007 pN2: Metastasis in 4 or more regional lymph nodes (colon/rectum)
396082002 pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney (kidney)
396083007 Kidney TNM finding
396084001 pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney (kidney)
396085000 pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney (kidney)
396086004 pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney)
396087008 pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney)
396088003 pT3a: Tumor directly invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney)
396089006 pT3b: Tumor grossly extends into the renal vein or its segmental (muscle-containing) branches, or vena cava below the diaphragm (kidney)
396090002 pT3c: Tumor grossly extends into vena cava above diaphragm or invades the wall of the vena cava (kidney)
396091003 pT4: Tumor invades beyond Gerota's fascia (kidney)
396092005 pN1: Metastasis in a single regional lymph node (kidney)
396093000 pN2: Metastasis in more than one regional lymph node (kidney)
396094006 Ampulla of Vater TNM finding
396095007 pT1: Tumor limited to ampulla of Vater or sphincter of Oddi (ampulla of Vater)
396096008 pT2: Tumor invades duodenal wall (ampulla of Vater)
396097004 pT3: Tumor invades pancreas (ampulla of Vater)
396098009 pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures (ampulla of Vater)
396099001 Liver TNM finding
396100009 pT1: Solitary tumor without vascular invasion (liver, including intrahepatic bile ducts)
396101008 pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts)
396102001 pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts)
396103006 pT4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum (liver, including intrahepatic bile ducts)
396282005 Uterine cervix TNM finding
396283000 pT1 (I): Cervical carcinoma confined to uterus (extension to corpus should be disregarded) (TNM category and FIGO stage) (uterine cervix)
396287004 pT1a (IA): Invasive carcinoma diagnosed only by microscopy. All macroscopically visible lesions (even with superficial invasion) are pT1b/IB (TNM category and FIGO stage) (uterine cervix)
396288009 pT1a1 (IA1): Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread (TNM category and FIGO stage) (uterine cervix)
396289001 pT1a2 (IA2): Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth and 7.0 mm or less horizontal spread (TNM category and FIGO stage) (uterine cervix)
396290005 pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix)
396291009 pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension (TNM category and FIGO stage) (uterine cervix)
396292002 pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension (TNM category and FIGO stage) (uterine cervix)
396294001 pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix)
396297008 pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix)
396298003 pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix)
396299006 pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix)
396300003 pT3a (IIIA): Tumor involves lower third of vagina, no extension to pelvic wall (TNM category and FIGO stage) (uterine cervix)
396301004 pT3b (IIIB): Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix)
396302006 pT4 (IVA): Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis (bullous edema is not sufficient evidence to classify a tumor as pT4) (TNM category and FIGO stage) (uterine cervix)
396303001 pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri)
396311006 Corpus uteri TNM finding
396312004 pT1 (I): Tumor confined to corpus uteri (TNM category and FIGO stage) (corpus uteri)
396313009 pT1a (IA): Tumor limited to endometrium (TNM category and FIGO stage) (corpus uteri)
396314003 pT1b (IB): Tumor invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri)
396315002 pT1c (IC): Tumor invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri)
396316001 pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri)
396317005 pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri)
396318000 pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri)
396319008 pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri)
396320002 pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) AND/OR cancer cells in ascites or peritoneal washings (TNM category and FIGO stage) (corpus uteri)
396321003 pT3b (IIIB): Involvement of vagina (direct extension or metastasis), rectal or bladder wall (without mucosal involvement), or pelvic wall(s) (frozen pelvis) (TNM category and FIGO stage) (corpus uteri)
396322005 pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa (TNM category and FIGO stage) (corpus uteri)
396323000 pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (corpus uteri)
396368008 Skin melanoma TNM finding
396369000 pTis: Melanoma in situ (melanoma of the skin)
396370004 pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (melanoma of the skin)
396371000 pT1a: Melanoma 1.0 mm or less in thickness and level II or III, no ulceration (melanoma of the skin)
396372007 pT1b: Melanoma 1.0 mm or less in thickness and level IV or V or with ulceration (melanoma of the skin)
396373002 pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin)
396374008 pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin)
396375009 pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin)
396376005 pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin)
396377001 pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration (melanoma of the skin)
396378006 pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration (melanoma of the skin)
396379003 pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration (melanoma of the skin)
396380000 pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration (melanoma of the skin)
396381001 pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration (melanoma of the skin)
396382008 pN1: Metastasis in one regional lymph node (melanoma of the skin)
396383003 pN1a: Clinically occult (microscopic) metastasis (melanoma of the skin)
396384009 pN1b: Clinically apparent (macroscopic) metastasis (melanoma of the skin)
396385005 pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis (melanoma of the skin)
396386006 pN2a: Clinically occult (microscopic) metastasis (melanoma of the skin)
396387002 pN2b: Clinically apparent (macroscopic) metastasis (melanoma of the skin)
396388007 pN2c: Satellite or in-transit metastasis without nodal metastasis (melanoma of the skin)
396389004 pN3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s) (melanoma of the skin)
396390008 pM1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes (melanoma of the skin)
396391007 pM1b: Metastasis to lung (melanoma of the skin)
396392000 pM1c: Metastasis to visceral site other than lung or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) (melanoma of the skin)
396492004 Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding
396493009 pT1: Tumor 2 cm or less in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396494003 pT1a: Tumor 2 cm or less in greatest dimension, limited to dermis or 2 mm or less in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396495002 pT1b: Tumor 2 cm or less in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396496001 pT1c: Tumor 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396497005 pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396498000 pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396499008 pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396500004 pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396501000 pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396502007 pT3a: Tumor more than 5 cm in greatest dimension, limited to dermis or not more than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396503002 pT3b: Tumor more than 5 cm in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396504008 pT3c: Tumor more than 5 cm in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396506005 pT4: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396507001 pT4b: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) greater than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396508006 pT4a: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) not more than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)
396532004 Stage I: Tumor confined to gland, 5 cm or less (adrenal cortical carcinoma)
396533009 Stage II: Tumor confined to gland, greater than 5 cm (adrenal cortical carcinoma)
396534003 Stage III: Extraglandular extension of tumor without other organ involvement (adrenal cortical carcinoma)
396535002 Stage IV: Distant metastasis or extension into other organs (adrenal cortical carcinoma)
396566008 Oropharynx TNM finding
396567004 pT1: Tumor 2 cm or less in greatest dimension (oropharynx)
396568009 Upper aerodigestive tract TNM finding
396569001 pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx)
396570000 pT3: Tumor more than 4 cm in greatest dimension (oropharynx)
396571001 pT4a: Tumor invades the larynx, deep/extrinsic muscle of tongue, medial pterygoid muscle, hard palate, or mandible (oropharynx)
396572008 pT4b: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery (oropharynx)
396573003 Lip and oral cavity TNM finding
396574009 pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity)
396575005 pT1: Tumor 2 cm or less in greatest dimension (lip and oral cavity)
396576006 pT1: Tumor 2 cm or less in greatest dimension
396577002 pT3: Tumor more than 4 cm in greatest dimension (lip and oral cavity)
396578007 pT4a: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose (lip)
396579004 pT4a: Tumor invades through cortical bone, into deep (extrinsic) muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), maxillary sinus, or skin of face (oral cavity)
396580001 pT4b: Tumor involves masticator space, pterygoid plates, or skull base and/or encases internal carotid artery (lip and oral cavity)
396581002 Hypopharyngeal TNM finding
396582009 Nasopharynx TNM finding
396583004 pT1: Tumor confined to the nasopharynx (nasopharynx)
396584005 pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx)
396585006 pT2: Tumor extends to the soft tissues (nasopharynx)
396586007 pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx)
396587003 pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx)
396588008 pT4: Tumor with intracranial extension, and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, orbit, or masticator space (nasopharynx)
396589000 pT1: Tumor limited to one subsite of hypopharynx and 2 cm or less in greatest dimension (hypopharynx)
396590009 pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx)
396591008 pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx)
396592001 pT4a: Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophagus or central compartment of soft tissue (hypopharynx)
396593006 pT4b: Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures (hypopharynx)
396594000 Supraglottis TNM finding
396595004 pT1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility (larynx, supraglottis)
396596003 pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx
396597007 pT3: Tumor limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis)
396598002 pT4a: Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, supraglottis)
396599005 pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, supraglottis)
396600008 Glottis TNM finding
396601007 pT1: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility (larynx, glottis)
396602000 pT1a: Tumor limited to one vocal cord (may involve anterior or posterior commissure) with normal mobility (larynx, glottis)
396603005 pT1b: Tumor involves both vocal cords (may involve anterior or posterior commissure) with normal mobility (larynx, glottis)
396604004 pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis)
396605003 pT3: Tumor limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis)
396606002 pT4a: Tumor invades through thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep intrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, glottis)
396607006 pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, glottis)
396608001 Subglottis TNM finding
396609009 pT1: Tumor limited to the subglottis (larynx, subglottis)
396610004 pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis)
396611000 pT3: Tumor limited to larynx with vocal cord fixation (larynx, subglottis)
396612007 pT4a: Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, subglottis)
396613002 pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, subglottis)
396614008 Maxillary sinus TNM finding
396615009 pT1: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone (maxillary sinus)
396616005 pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus)
396617001 pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus)
396618006 pT4a: Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses (maxillary sinus)
396619003 pT4b: Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus (maxillary sinus)
396621008 Nasal cavity and ethmoid sinus TNM finding
396622001 pT1: Tumor restricted to any one subsite, with or without bony invasion (nasal cavity and ethmoid sinus)
396623006 pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus)
396624000 pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus)
396625004 pT4a: Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses (nasal cavity and ethmoid sinus)
396626003 pT4b: Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus (nasal cavity and ethmoid sinus)
396632008 pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension (upper aerodigestive tract)
396633003 pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension (upper aerodigestive tract)
396634009 pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract)
396635005 pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract)
396636006 pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension (upper aerodigestive tract)
396637002 pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx)
396638007 pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx)
396639004 pN3: Metastasis in a lymph node(s), more than 6 cm in dimension, and/or to supraclavicular fossa (nasopharynx)
396640002 pN3a: Metastasis in a lymph node(s), more than 6 cm in dimension (nasopharynx)
396641003 pN3b: Metastasis in lymph node(s) residing wholly or in part in the supraclavicular fossa (nasopharynx)
396648009 Major salivary gland TNM finding
396650001 pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension (major salivary glands)
396651002 pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands)
396653004 pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension (major salivary glands)
396657003 pT4a: Tumor invades skin, mandible, ear canal, and/or facial nerve (major salivary glands)
396658008 pT4b: Tumor invades skull base and/or pterygoid plates and/or encases carotid artery (major salivary glands)
396666004 Urinary bladder, ureter, or renal pelvis TNM finding
396667008 pTa: Non-invasive papillary carcinoma (urinary bladder, ureter, renal pelvis)
396668003 pTis: Flat carcinoma in situ (urinary bladder, ureter, renal pelvis)
396669006 pT1: Tumor invades subepithelial connective tissue (urinary bladder, ureter, renal pelvis)
396670007 pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis)
396671006 pT2a: Tumor invades superficial muscle (inner half) (urinary bladder)
396672004 pT2b: Tumor invades deep muscle (outer half) (urinary bladder)
396673009 pT3: Tumor invades perivesical tissue (urinary bladder)
396674003 pT3a: Tumor invades perivesical tissue microscopically (urinary bladder)
396675002 pT3b: Tumor invades perivesical tissue macroscopically (extravesical mass) (urinary bladder)
396676001 pT4: Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall (urinary bladder)
396677005 pT4a: Tumor invades prostate or uterus or vagina (urinary bladder)
396678000 pT4b: Tumor invades pelvic wall or abdominal wall (urinary bladder)
396679008 pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension (urinary bladder, ureter, renal pelvis)
396680006 pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis)
396681005 pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis)
396682003 pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat (renal pelvis and ureter)
396683008 pT3: Tumor invades beyond muscularis into periureteric fat (ureter)
396684002 pT2: Tumor invades muscularis (renal pelvis and ureter)
396726006 Testis TNM finding
396727002 pTis: Intratubular germ cell neoplasia (carcinoma in situ) (testis)
396728007 pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis (testis)
396729004 pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis)
396730009 pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis)
396731008 pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion (testis)
396732001 pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension and less than or equal to 5 nodes positive, none more than 2 cm in greatest dimension (testis)
396733006 pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension of tumor (testis)
396734000 pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension (testis)
396735004 pM1a: Non-regional nodal or pulmonary metastasis (testis)
396736003 pM1b: Distant metastasis other than to non-regional lymph nodes and lungs (testis)
396797009 Exocrine pancreas TNM finding
396798004 pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension (exocrine pancreas)
396799007 pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas)
396800006 pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas)
396801005 pN1a: Metastasis in single regional lymph node (exocrine pancreas)
396802003 pN1b: Metastasis in multiple regional lymph node(s) (exocrine pancreas)
396803008 pT4: Tumor involves the celiac axis or the superior mesenteric artery (exocrine pancreas)
396907008 Thymic epithelial neoplasm stage finding
396908003 Stage I: Grossly and microscopically encapsulated (thymus gland)
396909006 Stage IIa: Microscopic transcapsular invasion (thymus gland)
396910001 Stage IIb: Macroscopic capsular invasion into thymic or surrounding fat, or grossly adherent to, but not breaking through, mediastinal pleura or pericardium (thymus gland)
396911002 Stage III: Macroscopic invasion of neighboring organs (thymus gland)
396912009 Stage IVa: Pleural or pericardial dissemination (thymus gland)
396913004 Stage IVb: Hematogenous or lymphatic dissemination (thymus gland)
396960007 Retinoblastoma TNM finding
396961006 pT1: Tumor confined to the retina, vitreous, or subretinal space. No optic nerve or choroidal invasion (retinoblastoma)
396962004 pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma)
396963009 pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma)
396964003 pT2b: Tumor invades choroid focally (retinoblastoma)
396965002 pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma)
396966001 pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma)
396967005 pT3a: Tumor invades optic nerve through the level of the lamina cribrosa but not to the line of resection (retinoblastoma)
396968000 pT3b: Tumor massively invades the choroid (retinoblastoma)
396969008 pT3c: Tumor invades the optic nerve through the level of the lamina cribrosa but not to the line of resection and massively invades the choroid (retinoblastoma)
396970009 pT4: Extraocular tumor extension which includes sites as per AJCC 6th Edition definition (retinoblastoma)
396971008 pM1a: Distant metastasis to bone marrow (retinoblastoma)
396972001 pM1b: Distant metastasis to sites other than bone marrow (retinoblastoma)
397025005 Stomach TNM finding
397026006 pT1: Tumor invades lamina propria or submucosa (esophagus)
397027002 Esophagus TNM finding
397029004 pT1a: Tumor invades lamina propria (esophagus)
397030009 pT1b: Tumor invades submucosa (esophagus)
397031008 pT2: Tumor invades muscularis propria (esophagus)
397032001 pT3: Tumor invades adventitia (esophagus)
397033006 pT4: Tumor invades adjacent structures (esophagus)
397036003 pN1a: Metastasis in 1 to 3 regional lymph nodes (esophagus)
397037007 pN1b: Metastasis in 4 to 7 regional lymph nodes (esophagus)
397038002 pN1c: Metastasis in more than 7 regional lymph nodes (esophagus)
397039005 pM1a: Metastasis in celiac lymph nodes (lower thoracic esophagus)
397040007 pM1a: Distant metastasis not applicable (midthoracic esophagus)
397041006 pM1a: Metastasis in cervical nodes (upper thoracic esophagus)
397042004 pM1b: Distant metastasis to site other than celiac lymph nodes (lower thoracic esophagus)
397043009 pM1b: Nonregional lymph nodes AND/OR other distant metastasis (midthoracic esophagus)
397044003 pM1b: Distant metastasis to site other than cervical nodes (upper thoracic esophagus)
397058001 Small intestine TNM finding
397059009 pT1: Tumor invades lamina propria or submucosa (small intestine)
397088005 pT2: Tumor invades muscularis propria (small intestine)
397089002 pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine)
397090006 pT4: Tumor perforates the visceral peritoneum or directly invades other organs or structures (small intestine)
397092003 Gallbladder TNM finding
397093008 pT1: Tumor invades lamina propria or muscle layer (gallbladder)
397094002 pT1a: Tumor invades lamina propria (gallbladder)
397095001 pT1b: Tumor invades muscle layer (gallbladder)
397096000 pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder)
397097009 pT3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts (gallbladder)
397098004 pT4: Tumor invades main portal vein or hepatic artery or invades two or more extrahepatic organs or structures (gallbladder)
397101000 Vagina TNM finding
397102007 pT1 (I): Tumor confined to vagina (TNM category and FIGO stage) (vagina)
397103002 pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina)
397104008 pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina)
397105009 pT4 (IVA): Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4) (TNM category and FIGO stage) (vagina)
397106005 pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina)
397107001 pN1: Pelvic or inguinal lymph node metastasis (vagina)
397119009 Vulva TNM finding
397120003 pT1 (I): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension (TNM category and FIGO stage) (vulva)
397121004 pT1a (IA): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm (TNM category and FIGO stage) (vulva)
397122006 pT1b (IB): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion greater than 1 mm (TNM category and FIGO stage) (vulva)
397123001 pT2 (II): Tumor confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva)
397124007 pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva)
397125008 pT4 (IVA): Tumor invades any of the following: upper urethra, bladder mucosa, rectal mucosa, or is fixed to the pubic bone (TNM category and FIGO stage) (vulva)
397126009 pN1: Unilateral regional lymph node metastasis (vulva)
397127000 pN2: Bilateral regional lymph node metastasis (vulva)
397146004 Extrahepatic bile ducts TNM finding
397147008 pT1: Tumor confined to the bile duct histologically (extrahepatic bile ducts)
397148003 pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts)
397149006 pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts)
397150006 pT4: Tumor invades any of the following: main portal vein or its branches bilaterally, common hepatic artery, or other adjacent structures, such as the colon, stomach, duodenum, or abdominal wall (extrahepatic bile ducts)
397213002 pM1a: Distant metastasis to non-regional lymph node(s) (prostate)
397214008 pM1b: Distant metastasis to bone(s) (prostate)
397215009 pM1c: Distant metastasis site other than bone or non-regional lymph node(s) (prostate)
397316007 Ovary TNM finding
397317003 pM1 (IV): Distant metastasis (TNM category and FIGO stage) (ovary)
397360007 pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) (TNM category and FIGO stage) (corpus uteri)
397367005 pN1 (III): Pelvic or inguinal lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vagina)
397368000 pN1 (IVA): Pelvic or inguinal lymph node metastasis (pT4) (TNM category and FIGO stage) (vagina)
397369008 pN1 (IVB): Pelvic or inguinal lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vagina)
397370009 pN1 (III): Unilateral regional lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vulva)
397371008 pN1 (IVA): Unilateral regional lymph node metastasis (pT4) (TNM category and FIGO stage) (vulva)
397372001 pN1 (IVB): Unilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva)
397373006 pN2 (IVA): Bilateral regional lymph node metastasis (pT1-pT4) (TNM category and FIGO stage) (vulva)
397374000 pN2 (IVB): Bilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva)
397375004 pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva)
397385003 Thoracic mesothelioma TNM finding
397386002 pT1: Tumor involves ipsilateral parietal pleura, with or without focal involvement of visceral pleura (thoracic mesothelioma)
397387006 pT1a: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura. No involvement of the visceral pleura (thoracic mesothelioma)
397388001 pT1b: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura, with focal involvement of the visceral pleura (thoracic mesothelioma)
397389009 pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma)
397390000 pN1: Metastasis in the ipsilateral bronchopulmonary and/or hilar lymph node(s) (thoracic mesothelioma)
397391001 pN2: Metastasis in the subcarinal lymph node(s) and/or the ipsilateral internal mammary or mediastinal lymph node(s) (thoracic mesothelioma)
397392008 pN3: Metastasis in the contralateral mediastinal, internal mammary, or hilar lymph node(s), and/or the ipsilateral or contralateral supraclavicular or scalene lymph node(s) (thoracic mesothelioma)
397393003 pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma)
397465003 pT4: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma)
397470005 Gestational trophoblast TNM finding
397471009 pT1 (I): Tumor confined to uterus (TNM category and FIGO stage) (gestational trophoblast)
397472002 pT2 (II): Tumor extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast)
397473007 pM1a (III): Tumor extends to the lungs with or without genital tract involvement (TNM category and FIGO stage) (gestational trophoblast)
397474001 pM1b (IV): Distant metastasis other than lung (TNM category and FIGO stage) (gestational trophoblast)
397489005 pT1 (I): Tumor limited to ovaries (one or both) (TNM category and FIGO stage) (ovary)
397490001 pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)
397491002 pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)
397492009 pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)
397493004 pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary)
397494005 pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)
397495006 pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)
397496007 pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)
397497003 pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary)
397498008 pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) (TNM category and FIGO stage) (ovary)
397499000 pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension (TNM category and FIGO stage) (ovary)
397500009 pT3c AND/OR N1 (IIIC): Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension AND/OR regional lymph node metastasis (TNM category and FIGO stage) (ovary)
397501008 Any T/any N and M1 (IV): Growth involving one or both ovaries with distant metastasis. (TNM category and FIGO stage) (ovary)
399378007 pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube)
399393006 pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid)
399397007 pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma)
399400003 pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands)
399401004 Insufficient tissue to assess highest pT category
399404007 pT3b (IIIB): Tumor involves one or both fallopian tubes, with macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension (TNM category and FIGO stage) (fallopian tube)
399410007 pT3c (IIIC): Tumor involves one or both fallopian tubes, with peritoneal metastasis outside the pelvis more than 2 cm in diameter (TNM category and FIGO stage) (fallopian tube)
399413009 Thyroid TNM finding
399425007 pT1a (IA): Tumor limited to one fallopian tube, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube)
399439007 pT1: Tumor 2 cm or less in greatest dimension limited to the thyroid (thyroid)
399446003 pT4b: Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels (thyroid)
399448002 pT1: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) (ciliary body and choroid) (uveal melanoma)
399452002 pM1b: Distant metastasis (esophagus)
399453007 No pT1 category, insufficient tissue (prostate)
399454001 pT1c (IC): Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube)
399461002 pT1b: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)
399474008 pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma)
399478006 pT1 (I): Tumor limited to the fallopian tube(s) (TNM category and FIGO stage) (fallopian tube)
399481001 pN1a: Metastasis to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) (thyroid)
399493005 pT1c: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma)
399501001 pT1: Tumor limited to the iris (iris) (uveal melanoma)
399508007 pT4b: Extrathyroidal anaplastic carcinoma - surgically unresectable (anaplastic carcinoma) (thyroid)
399511008 pT1b: Tumor limited to the iris (more than 3 clock hours in size) (iris) (uveal melanoma)
399516003 pT1a: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)
399517007 Tumor stage cannot be determined
399518002 pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid)
399519005 pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)
399543008 pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma)
399553009 pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis)
399557005 pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma)
399575006 pT4a: Intrathyroidal anaplastic carcinoma - surgically resectable (anaplastic carcinoma) (thyroid)
399594001 pM1a: Distant metastasis (esophagus)
399597008 pT1a: Tumor limited to the iris (not more than 3 clock hours in size) (iris) (uveal melanoma)
399602001 pT1c: Tumor limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma)
399605004 FIGO stage finding for fallopian tube tumor
399610000 pT3: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma)
399615005 pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma)
399616006 pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)
399621009 pT3a (IIIA): Tumor involves one or both fallopian tubes, with microscopic peritoneal metastasis outside the pelvis (TNM category and FIGO stage) (fallopian tube)
399623007 pT4a: Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve (thyroid)
399630001 pT category not identified
399636007 pT3c and/or N1 (IIIC): Tumor involves one or both fallopian tubes, with peritoneal metastasis outside the pelvis more than 2 cm in diameter AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube)
399641004 pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube)
399674004 pT3a: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension and melanomalytic glaucoma (iris) (uveal melanoma)
399678001 pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube)
399679009 pT4: Tumor with extraocular extension (iris) (uveal melanoma)
399688000 Fallopian tube TNM finding
399690004 pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube)
399696005 pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube)
399697001 pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube)
399704006 pN1b: Metastasis to unilateral, bilateral, or contralateral cervical or superior mediastinal lymph nodes (thyroid)
399705007 Uveal melanoma TNM finding
399729000 pT4: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) with extraocular extension (ciliary body and choroid) (uveal melanoma)
399736004 pT1b (IB): Tumor limited to both tubes, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube)
399749009 Any T/Any N and M1 (IV): Distant metastasis including presence of malignant cells in pleural fluid or parenchymal hepatic metastasis (TNM category and FIGO stage) (fallopian tube)
404180008 pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis)
404181007 pM1 (IV): Distant metastasis (TNM category and FIGO stage) (fallopian tube)
404182000 pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (uterine cervix)
405917009 Intergroup rhabdomyosarcoma study post-surgical clinical group finding
405918004 Intergroup rhabdomyosarcoma study post-surgical clinical group not applicable
405919007 Intergroup rhabdomyosarcoma study post-surgical clinical group cannot be assessed
405957007 Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected
405958002 Intergroup rhabdomyosarcoma study post-surgical clinical group IB: localized tumor, infiltrating beyond site of origin, completely resected
405959005 Intergroup rhabdomyosarcoma study post-surgical clinical group IIA: localized tumor, gross total resection, but with microscopic residual disease
405960000 Intergroup rhabdomyosarcoma study post-surgical clinical group IIB: Locally extensive tumor (spread to regional lymph nodes), completely resected
405961001 Intergroup rhabdomyosarcoma study post-surgical clinical group IIC: Locally extensive tumor (spread to regional lymph nodes), gross total resection, but microscopic residual disease
405962008 Intergroup rhabdomyosarcoma study post-surgical clinical group IIIA: Localized or locally extensive tumor, gross residual disease after biopsy only
405963003 Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50% debulking)
405964009 Intergroup rhabdomyosarcoma study post-surgical clinical group IV: Any size primary tumor, with or without regional lymph node involvement, with distant metastases, without respect to surgical approach to primary tumor
405992004 pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (ovary)
406001009 pT4b: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases internal carotid artery (oropharynx)
406088001 pN0(i-): No regional lymph node metastasis histologically, negative morphologic findings for isolated tumor cells (breast)
406089009 pN0(i+): No regional lymph node metastasis histologically, positive morphologic findings for isolated tumor cells, no cluster greater than 0.2 mm (breast)
406090000 pN0(mol-): No regional lymph node metastasis histologically, negative nonmorphologic (molecular) findings for isolated tumor cells (breast)
406091001 pN0(mol+): No regional lymph node metastasis histologically, positive nonmorphologic (molecular) findings for isolated tumor cells (breast)
406092008 pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube)
409721000 International neuroblastoma staging system stage finding
409722007 International neuroblastoma staging system stage 1
409723002 International neuroblastoma staging system stage 2A
409724008 International neuroblastoma staging system stage 2B
409725009 International neuroblastoma staging system stage 3
409726005 International neuroblastoma staging system stage 4
409727001 International neuroblastoma staging system stage 4S
409747009 pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)
409748004 pT1: Tumor 5 cm or less in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)
409749007 pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)
409750007 pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)
409751006 pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)
409752004 pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)
409753009 pT1: Tumor 8 cm or less in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma)
409754003 pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma)
409755002 pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma)
409756001 Primitive neuroectodermal tumor/Ewing's sarcoma TNM finding
409758000 pM1a: Distant metastasis to lung (primitive neuroectodermal tumor/Ewing's sarcoma)
409759008 pM1b: Distant metastasis to site other than lung (primitive neuroectodermal tumor/Ewing's sarcoma)
422375001 Carcinoma of colon, stage III
422399001 Infiltrating ductal carcinoma of breast, stage 1
422479008 Infiltrating ductal carcinoma of breast, stage 2
422581008 Carcinoma of colon, stage II
422679002 Seminoma of testis, stage 3
422807001 pT4: Tumor directly invades other organs or structures and/or perforates visceral peritoneum (appendix)
422901001 pTis: Carcinoma in situ, intraepithelial (appendix)
422985007 Carcinoma of colon, stage IV
423003009 pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix)
423055005 pTis: Carcinoma in situ, invasion of lamina propria (appendix)
423114009 Infiltrating ductal carcinoma of breast, stage 3
423274005 Carcinoma of ovary, stage 4
423480004 Carcinoma of ovary, stage 3
423645007 Seminoma of testis, stage 2
423697000 Seminoma of testis, stage 4
423816008 Seminoma of testis, stage 1
424078005 Adenocarcinoma of lung, stage I
424229006 Infiltrating ductal carcinoma of breast, stage 4
424454009 Adenocarcinoma of lung, stage III
424486004 Carcinoma of ovary, stage 2
424600001 Carcinoma of ovary, stage 1
424632001 Adenocarcinoma of lung, stage II
424842001 pT1: Tumor invades submucosa (appendix)
424993006 Adenocarcinoma of lung, stage IV
425008003 pT2: Tumor invades muscularis propria (appendix)
425037004 Low grade lymphoma, stage 1
425213009 Carcinoma of colon, stage I
425566006 pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (soft tissue)
426288003 pM1b: Distant metastasis to site other than lung (bone)
426554005 pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue)
426561009 Bone TNM finding
426613005 pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue)
426616002 pT2: Tumor more than 8 cm in greatest dimension (bone)
426897009 pT1: Tumor 8 cm or less in greatest dimension (bone)
426917009 pM1a: Distant metastasis to lung (bone)
427209003 pT3: Discontinuous tumors in the primary bone site (bone)
427495001 pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor (soft tissue)
427535001 Soft tissue TNM finding
443335006 pN0(i-) category
443357004 pT1a category
443452006 pN2b category
443479005 pT3d category
443486002 pN0(i+) category
443505003 pT4d category
443506002 pT1b category
443599002 pN1b category
443600004 pT1mic category
443604008 pT4a category
443606005 pT3a category
443642002 pT1c category
443674009 pT3c category
443716008 pN1a category
443721006 pT4c category
443736009 pT4b category
443743003 pN1c category
443784000 pT3c,d category
443812002 pT2a category
443815000 pT3a,b category
443817008 pT3b category
443823003 pN3c category
443824009 pN1mi category
443839005 pM1c category
443840007 pM1b category
443841006 pM1a category
443866005 pN3a category
443867001 pN2a category
443875007 pN0(mol+) category
443893008 pN2c category

 

See the full registry of value sets defined as part of FHIR.


Explanation of the columns that may appear on this page:

LvlA few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code